- Home
- LFT vs FBIO Comparison
LFT vs FBIO Comparison
Compare LFT & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFT
- FBIO
- Stock Information
- Founded
- LFT 2012
- FBIO 2006
- Country
- LFT United States
- FBIO United States
- Employees
- LFT N/A
- FBIO N/A
- Industry
- LFT Real Estate Investment Trusts
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LFT Real Estate
- FBIO Health Care
- Exchange
- LFT Nasdaq
- FBIO Nasdaq
- Market Cap
- LFT 82.2M
- FBIO 88.7M
- IPO Year
- LFT N/A
- FBIO N/A
- Fundamental
- Price
- LFT $1.62
- FBIO $2.75
- Analyst Decision
- LFT Hold
- FBIO Strong Buy
- Analyst Count
- LFT 1
- FBIO 2
- Target Price
- LFT N/A
- FBIO $16.50
- AVG Volume (30 Days)
- LFT 224.7K
- FBIO 341.4K
- Earning Date
- LFT 11-12-2025
- FBIO 11-14-2025
- Dividend Yield
- LFT 10.06%
- FBIO N/A
- EPS Growth
- LFT N/A
- FBIO N/A
- EPS
- LFT 0.09
- FBIO N/A
- Revenue
- LFT $21,708,246.00
- FBIO $62,303,000.00
- Revenue This Year
- LFT $124.75
- FBIO $31.85
- Revenue Next Year
- LFT N/A
- FBIO $44.43
- P/E Ratio
- LFT $16.89
- FBIO N/A
- Revenue Growth
- LFT N/A
- FBIO N/A
- 52 Week Low
- LFT $1.42
- FBIO $1.33
- 52 Week High
- LFT $2.84
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- LFT 52.09
- FBIO 55.02
- Support Level
- LFT $1.42
- FBIO $2.40
- Resistance Level
- LFT $1.56
- FBIO $2.76
- Average True Range (ATR)
- LFT 0.06
- FBIO 0.16
- MACD
- LFT 0.03
- FBIO 0.03
- Stochastic Oscillator
- LFT 95.00
- FBIO 94.59
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.